Clinical Trial Update: Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease [NA]

View source ↗

Summary

Clinical trial evaluating iloprost for pulmonary hypertension in adults with congenital heart disease was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Eisenmenger Syndrome
• Pulmonary Arterial Hypertension

Drugs mentioned

• Ventavis (iloprost) (iloprost)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Pulmonary Arterial Hypertension, Congenital Heart Disease | NA | Status: TERMINATED | Results posted: 2014-12-29